NCT06802549

Outcomes of Partial Pulpotomy Treatment in Cariously Exposed Teeth

Treatment Outcomes of Partial Pulpotomy Using Two Different Calcium Silicate Materials in Cariously Exposed Mature Permanent Teeth: A Randomized Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 61 (actual)
• Sponsor: Firat University · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The aim of this clinical trial is to learn how successful Biodentine and Theracal PT dental filling materials are in treating deep tooth decay in adults. It will also provide information about post-treatment pain. The main questions it aims to answer are: Do Biodentine and Theracal PT dental filling materials treat exposed tooth decay in participants? Do they reduce the need for root canal treatment? After the application of Biodentine and Theracal PT dental filling materials to the participants, the pain and symptoms that cause pain may not decrease. In this case, the tooth may be treated with root canal treatment. The researchers will compare the clinical success of Biodentine and Theracal PT dental filling materials with each other. Participants will undergo a single-session partial pulpotomy treatment with the dental filling materials mentioned above. Clinical and radiographic follow-ups will then be performed at 3, 6 and 12 months, and records will be kept.

Conditions

• Deep Dental Caries

Interventions

Type	Name	Description
DEVICE	Biodentine (calcium silicate-based cement) (Septodont, Saint Maur de Fossés, France)	It will be placed on the exposed pulp with the help of a carrier and the exposed pulp will be covered with material
DEVICE	Theracal PT (resin modified calcium silicate-based cement) (Bisco Inc., Schaumburg, IL, USA)	It will be placed on the exposed pulp with the help of its injection tip and the exposed pulp will be covered with material

Timeline

• Start date: 2024-03-20
• Primary completion: 2025-06-15
• Completion: 2025-06-20
• First posted: 2025-01-31
• Last updated: 2025-09-23

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

• FDA-regulated device study